:::

詳目顯示

回上一頁
題名:臺灣低劑量荷爾蒙補充療法的爭議:知識、實作與標準化
書刊名:科技、醫療與社會
作者:楊舒琴盧孳艷
作者(外文):Yang, Shu-chinLu, Jane Zxy-yann
出版日期:2016
卷期:23
頁次:頁203-256
主題關鍵詞:更年期低劑量荷爾蒙補充療法區域聯盟MenopauseLow doesHormone replacement therapyMenopausal hormone therapyRegional alliance
原始連結:連回原系統網址new window
相關次數:
  • 被引用次數被引用次數:期刊(0) 博士論文(0) 專書(0) 專書論文(0)
  • 排除自我引用排除自我引用:0
  • 共同引用共同引用:90
  • 點閱點閱:21
期刊論文
1.Lock, Margaret、Kaufert, Patricia(2001)。Menopause, Local Biologies and Cultures of Aging。American Journal of Human Biology,13(4),494-504。  new window
2.張珣(20110600)。日常生活中「虛」的身體經驗。考古人類學刊,74,11-52。new window  延伸查詢new window
3.張玨(20030800)。更年期婦女健康是公共衛生政策的議題。臺灣公共衛生雜誌,22(4),245-250。new window  延伸查詢new window
4.Kuo, Wen-Hua(2009)。The Voice on the Bridge: Taiwan's Regulatory Engagement with Global Pharmaceuticals。East Asian Science, Technology and Society: An International Journal,3(1),51-72。new window  new window
5.盧孳艷、林雪貴(20010200)。更年期的論述分析。護理雜誌,48(1),77-82。new window  延伸查詢new window
6.林文源(20121200)。醫療化理論的後進國批判:以臺灣慢性腎病治理的知識、專業與體制轉變為例。臺灣社會學,24,1-53。new window  延伸查詢new window
7.張玨、陳芬苓(20001000)。臺灣婦女健康政策的性別分析。中華公共衛生雜誌,19(5),366-380。new window  延伸查詢new window
8.張玨、張菊惠(19980400)。婦女健康與「醫療化」:以停經期/更年期為例。婦女與兩性學刊,9,145-185。new window  延伸查詢new window
9.Zola, Irving Kenneth(1972)。Medicine as an Institution of Social Control。Sociological Review,20,487-504。  new window
10.Stampfer, M. J.、Colditz, G. A.、Willett, W. C.、Manson, J. E.、Rosner, B.、Speizer, F. E.、Hennekens, C. H.(1991)。Postmenopausal estrogen therapy and cardiovascular disease: Ten-year follow-up from the nurses' health study。The New England Journal of Medicine,325(11),756-762。  new window
11.王家瑋(2006)。停藥--to be or not to be。更年期保健諮詢專線充電報,2,3-4。  延伸查詢new window
12.成令方(20100300)。更年期不是病~向醫療化Say No。醫療品質雜誌,4(2),71-74。new window  延伸查詢new window
13.吳佳珮(2002)。國內人權新聞。人權雜誌,秋季號,54。  延伸查詢new window
14.洪煥程、鄭敏慧、趙灌中、袁九重、趙湘台、王鵬惠(20070400)。停經後婦女之低劑量荷爾蒙療法與乳房癌症。中華民國婦癌醫學雜誌,1,67-73。  延伸查詢new window
15.張珏、吳佩樺、張菊惠、蔡宗仁、徐黎玲、李旻貞(19990600)。中年婦女血中荷爾蒙濃度與停經狀態--橫斷式研究初探。中華公共衛生雜誌,18(3),209-221。new window  延伸查詢new window
16.鄭欣宜(2013)。停經後荷爾蒙治療--2013國際更年期醫學會(International Menopause Society)最新臨床建議。台灣更年期醫學會會刊,43,17-19。  延伸查詢new window
17.盧孳艷、陳海焦(20070400)。更年期婦女之骨質疏鬆篩檢政策--風險與規訓。護理雜誌,54(2),23-28。new window  延伸查詢new window
18.Ausmanas, Militza K.、Holinka, Christian F.、Ling, Yu Su、Christiansen, Claus(2007)。Effect of Three Doses of Conjugated Estrogens/medroxyprogesterone Acetate on Biomarkers of Bone Turnover and Cartilage Degradation in Postmenopausal Women: The Pan-Asia Menopause(PAM) study。Climacteric,10,306-313。  new window
19.Ausmanas, Militza K.、Tan, Delfin A.、Jaisamrarn, Unnop、Tian, Xiao Wei、Holinka, Christian F.(2007)。Estradiol, FSH and LH Profiles in Nine Ethnic Groups of Postmenopausal Asian Women: the Pan-Asia Menopause(PAM) study。Climacteric,10,427-437。  new window
20.Burger, Henry G.、MacLennan, Alastair H.、Huang, Ko-En、Castelo-Branco, Camil(2012)。Evidence-based Assessment of the Impact of the WHI on Women's Health。Climacteric,15,281-287。  new window
21.Crump, Kenny S.、Hoel, David G.、Langley, C. H.、Peto, R.(1976)。Fundamental Carcinogenic Processes and their Implications for Low Dose Risk Assessment。Cancer Research,36,2973-2979。  new window
22.Davis, Dona L.(1997)。Blood and Nerves Revisited: Menopause and the Privatization of the Body in a Newfoundland Postindustrial Fishery。Medical Anthropology Quarterly,11,3-20。  new window
23.De Villiers, T. J.、Gass, M. L. S.、Haines, C. J.、Hall, J. E.、Lobo, R. A.、Pierroz, D. D.、Rees, M.(2013)。Global Consensus Statement on Menopausal Hormone Therapy。Climacteric,16,203-204。  new window
24.Gambacciani, Marco、Genazzani, Andrea Riccardo(2001)。Hormone Replacement Therapy: the Benefits in Tailoring the Regimen and Dose。Maturitas,40,195-201。  new window
25.Gambacciani, Marco、Monteleone, Patrizia、Genazzani, Andrea Riccardo(2002)。Low-dose Hormone Replacement Therapy: Effects on Bone。Climacteric,5,135-139。  new window
26.Garcia-Perez, M.、Moreno-Mercer, J.、Tarin, J. J.、Cano, A.(2006)。Similar Efficacy of Low and Standard Doses of Transdermal Estradiol in Controlling Bone Turnover in Postmenopausal Women。Gynecological Endocrinology,22,179-184。  new window
27.Genant, Harry K.、Cann, Christopher E.、Ettinger, Bruce、Gordan, Gilbert S.(1982)。Quantitative Computed Tomography of Vertebral Spongiosa: a Sensitive Method for Detecting early Bone Loss after Oophorectomy。Annals of Internal Medicine,97,699-705。  new window
28.Haines, Christopher J.、Xing, Shu-Min、Park, Ki-Hyun、Holinka, Christian F.、Ausmanas, Militza K.(2005)。Prevalence of Menopausal Symptoms in Different Ethnic Groups of Asian Women and Responsiveness to Therapy with Three Doses of Conjugated Estrogens/medroxyprogesterone Acetate: the Pan-Asia Menopause (PAM) study。Maturitas,52,264-276。  new window
29.Holinka, Christian F.、Christiansen, Claus、Tian, Xiao Wei、Ausmanas, Militza K.(2008)。Ethnic Differences in Levels of Bone and Cartilage Biomarkers and Hormonal Responsiveness in Nine Groups of Postmenopausal Asian Women: the Pan-Asia Menopause (PAM) study。Climacteric,11,44-54。  new window
30.Huang, W. F.、Tsai, Y. W.、Hsiao, F. Y.、Liu, W. C.(2007)。Changes of the Prescription of Hormone Therapy in Menopausal Women: An Observational Study in Taiwan。BMC Public Health,7,56-10。  new window
31.Järvinen, A.、Kainulainen, P.、Nissilä, M.、Nikkanen, H.、Kela, M.(2004)。Pharmacokinetics of Estradiol Valerate and Medroxyprogesterone Acetate in Different Age Groups of Postmenopausal Women。Maturitas,47,209。  new window
32.Klein, Renate、Dumble, Lynette J.(1994)。Disempowering Midlife Women: The Science and Politics of Hormone Replacement Therapy (HRT)。Women's Studies International Forum,17,327-343。  new window
33.Limpaphayom, Khunying Kobchitt、Darmasetiawan, Sjarief、Hussain, Rubina I.、Burriss, S. W.、Holinka, Christian F.、Ausmanas, Militza K.(2006)。Differential Prevalence of Quality-of-life Categories (domains) in Asian Women and Changes after Therapy with Three Doses of Conjugated Estrogens/medroxyprogesterone Acetate: the Pan-Asia Menopause (PAM) study。Climacteric,9,204-214。  new window
34.Lindsay, Robert、Hart, David M.、Clark, D. M.(1984)。The Minimum Effective Dose of Estrogen for Prevention of Postmenopausal Bone Loss。Obstetrics and Gynecology,63(5),759-763。  new window
35.Lobo, Rogerio A.、Whitehead, Malcolm I.(2001)。Is Low-dose Hormone Replacement Therapy for Postmenopausal Women Efficacious and Desirable?。Climacteric,4(2),110-119。  new window
36.Lobo, Rogerio A.、Pickar, James H.、Wild, Robert A.、Walsh, Rian、Hirvonen, Erkki(1994)。Metabolic impact of adding medroxyprogesterone acetate to conjugated estrogen therapy in postmenopausal women. The Menopause Study Group。Obstetrics & Gynecology,84(6),987-995。  new window
37.MacLennan, Alastair H.(2011)。HRT in Difficult Circumstances: are there any Absolute Contraindications?。Climacteric,14,409-417。  new window
38.McCrea, Frances B.、Markle, Gerald E.(1984)。The Estrogen Replacement Controversy in the USA and UK: Different Answers to the Same Question?。Social Studies of Science,14,1-26。  new window
39.Morse, Janice M.(2015)。Critical Analysis of Strategies for Determining Rigor in Qualitative Inquiry。Qualitative Health Research,25(9),1212-1222。  new window
40.Pasley, Beverly H.、Standfast, Susan J.、Katz, Selig H.(1984)。Prescribing Estrogen during Menopause: Physician Survey of Practices in 1974 and 1981。Public Health Report,99,424-429。  new window
41.Peeyananjarassri, Krantarat、Baber, Rodney(2005)。Effects of Low-dose Hormone Therapy on Menopausal Symptoms, Bone Mineral Density, Endometrium, and the Cardiovascular System: a Review of Randomized Clinical Trials。Climacteric,8,13-23。  new window
42.Pines, Amos、Sturdee, David William、Birkhauser, Martin H.、Schneider, Hermann P. G.、Gambacciani, Genazzani, M.、Panay, Nick(2007)。IMS Updated Recommendations on Postmenopausal Hormone Therapy。Climacteric,10,181-194。  new window
43.Ramirez, Michelle(2006)。Manufacturing Heterosexuality: Hormone Replacement Therapy and Menopause in Urban Oaxaca。Culture, Health and Sexuality,8,545-558。  new window
44.Rossouw, Jacques E.、Anderson, Garnet L.、Prentice, Ross L.、LaCroix, Andrea Z.、Kooperberg, Charles、Stefanick, Marcia L.、Jackson, Rebecca D.、Beresford, Shirley A. A.、Howard, Barbara V.、Johnson, Karen C.、Kotchen, Jane Morley、Ockene, Judith(2002)。Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results from the Women's Health Initiative Randomized Controlled Trial。JAMA: The Journal of the American Medical Association,288(3),321-333。  new window
45.Stefanick, Marcia L.(2005)。Estrogens and Progestins: Background and History, Trends in Use, and Guidelines and Regimens Approved by the US Food and Drug Administration。The American Journal of Medicine,118,64-73。  new window
46.Sturdee, David W.、MacLennan, Alastair H.(2005)。Editorial: How low can you go?。Climacteric,8,305-306。  new window
47.Taechakraichana, Nimit、Holinka, Christian F.、Haines, Christopher J.、Subramaniam, Rajeshwari、Tian, Xiao Wei、Ausmanas, Militza K.(2007)。Distinct lipid/lipoprotein Profiles and Hormonal Responsiveness in Nine Ethnic Groups of Postmenopausal Asian Women: the Pan-Asia Menopause (PAM) Study。Climacteric,10,225-237。  new window
48.Tan, Delfin、Darmasetiawan, Sjarief、Haines, Christopher J.、Huang, Ko-En、Jaisamram, Unnop、Limpaphayom, Khunying Kobchitt、Lin, Shou-Qing、Ling, Yu Su、Nguyen, Thi Ngoc Phuong、Park, Ki-Hyun、Shah, Nina D.、Subramaniam, Rajeshwari、Taechakraichana, Nimit、Xing, Shun Min(2006)。Guidelines for Hormone Replacement Therapy of Asian Women during the Menopausal Transition and thereafter。Climacteric,9,146-151。  new window
49.Tan, Delfin、Haines, Christopher J.、Limpaphayom, Khunying Kobchitt、Holinka, Christian F.、Ausmanas, Militza K.(2005)。Relief of Vasomotor Symptoms and Vaginal Atrophy with Three Doses of Conjugated Estrogens and Medroxyprogesterone Acetate in Postmenopausal Asian Women from 11 Countries: The Pan-Asia menopause (PAM) study。Maturitas,52,35-51。  new window
50.Tsai, Sandra A.、Stefanick, Marcia L.、Stafford, Randall S.(2011)。Trends in Menopausal Hormone Therapy Use of US office-based physicians, 2000-2009。Menopause,18,385-392。  new window
51.Yasui, T.、Uemura, H.、Takikawa, M.、Saito, S.、Kuwahara, A.、Irahara, M.、Umino, Y.(2005)。Serum Estrogen Level after Hormone Replacement Therapy and Body Mass Index in Postmenopausal and Bilaterally Ovariectomized Women。Maturitas,50,19-29。  new window
52.Vance, Dwight A.(2007)。Premarin: The Intriguing History of a Controverisal Drug。International Journal of Pharmaceutical Compounding,11,282-286。  new window
53.Wu, C. Y、Wu, S. L.、Lin, S. J.、Chu, C. M. Y.(2011)。Changes in Hormone Therapy Prescriptions Among Middle-Aged Women in Taiwan: Implications for Health Needs at Menopause。Women's Health Issues,21,153-159。  new window
54.Bergkvist, L.、Adami, H. O.、Persson, I.、Hoover, R.、Schairer, C.(1989)。The Risk of Breast Cancer after Estrogen and Estrogen-progestin Replacement。New England Journal of Medicine,321,293-297。  new window
55.張珏、周松男、陳芬苓、張菊惠(19950400)。一般經期與更年期自述症狀的研究。中華公共衛生雜誌,14(2),191-200。new window  延伸查詢new window
會議論文
1.成令方(2013)。更年期政策的轉變1990-2010。第二屆「性別研究與社會革新」學術研討會:「解構二元:理論與實踐的交織和辯證」。高雄:高雄醫學大學。  延伸查詢new window
研究報告
1.盧孳艷、劉嘉耀(2004)。性別、階級與醫療科技:荷爾蒙補充療法(HRT)之在地體現經驗 (計畫編號:NSC92-2420-H-010-002)。台北:行政院國家科學委員會。  延伸查詢new window
學位論文
1.吳堃銘(2008)。更年期醫療論述在台灣的建構與轉變過程(碩士論文)。高雄醫學大學,高雄。  延伸查詢new window
2.蔡宛芬(2005)。2002年美國WHI報告後台灣更年期論述之樣貌(碩士論文)。國立陽明大學,台北。  延伸查詢new window
圖書
1.Lock, Margaret M.(1993)。Encounters with Aging: Mythologies of Menopause in Japan and North America。Berkeley, CA:University of California Press。  new window
2.Conrad, Peter(2007)。The Medicalization of Society: On the Transformation of Human Conditions into Treatable Disorders。Baltimore, Maryland:Johns Hopkins University Press。  new window
3.衛生福利部(2014)。中華民國103年版衛生福利年報。台北:衛生福利部。  延伸查詢new window
4.衛生福利部國民健康署(2013)。婦女更年期保健手冊--迎接人生新旅程手冊。台北:衛生福利部。  延伸查詢new window
5.Barnes, Barry、Shapin, Steven(1979)。Natural Order: Historical Studies of Scientific Culture。Sage Publications。  new window
6.Illich, Ivan(1976)。Medical Nemesis: the Exporpriation of Health。New York:Pantheon。  new window
7.Roberts, Celia(2007)。Messengers of Sex: Hormones, Biomedicine and Feminism。Cambridge Universal Press。  new window
8.Berg, Marc、Timmermans, Stefan(2003)。The Gold Standard: the Challenge of Evidence-Based Medicine and Standardization in Health Care。Philadelphia:Temple University Press。  new window
其他
1.王怡君(2004)。台灣更年期醫學會提十項荷爾蒙治療指引,http://www.wtbn.org/487/p487-06-14.shtm。  延伸查詢new window
2.台灣女人連線(2002)。台女連2002大事紀,http://twl.ngo.org.tw/history。  延伸查詢new window
3.台灣更年期學會(2002)。透視荷爾蒙替代療法的真相,http://hospital.kingnet.com.tw/essay/essay.html?pid=3073&category=%C2%E5%C3%C4%AFe%AFf&type=。  延伸查詢new window
4.台灣更年期學會(2004)。2004年台灣更年期醫學會荷爾蒙治療指引,http://www.menopause.org.tw/newsdetail.php?title_id=5&ca_id=12&news_id=238。  延伸查詢new window
5.台灣更年期學會(2007)。2007年台灣更年期醫學會荷爾蒙治療指引,http://www.menopause.org.tw/hot_article.php?page_type=knowledge&no=3&page_btype=4。  延伸查詢new window
6.(19950912)。黃金女郎安度更年期,補充荷爾蒙要當心。沿用外國報告有過量之虞,未適當併服黃體素有致癌危機險。國內十一大醫院將合作研究找出適合國人劑量及使用方法。  延伸查詢new window
7.吳靜美(20020227)。高齡婦女補骨本考慮低劑量雌激素。  延伸查詢new window
8.呂玲玲(19971214)。醫療熱線荷爾蒙劑量因人而異,長期補充者每年應做子宮頸抹片及乳癌檢查。  延伸查詢new window
9.國家網路醫院(2007)。全球趨勢亞洲實證,更年期婦女如何有效緩解症狀?,http://hospital.kingnet.com.tw/essay/essay.html?pid=15198。  延伸查詢new window
10.張正莉(19991223)。荷爾蒙療法劑量如何?。  延伸查詢new window
11.許文德(19990814)。荷爾蒙劑量老少有別,服用前請先諮詢醫師。  延伸查詢new window
12.黃國恩(2007)。不一樣的聲音以低劑量為導向,探索荷爾蒙療法!,http://hospital.kingnet.com.tw/essay/essay.html?pid=14774。  延伸查詢new window
13.衛生福利部國民健康署(2015)。更年期保健,http://www.hpa.gov.tw/BHPNet/Web/HealthTopic/Topic.aspx?id=200712250020。  延伸查詢new window
14.(19990419)。更年期婦女改善症狀再等一等,適合台灣婦女的荷爾蒙劑量,明年二月才能找出。  延伸查詢new window
15.Asia Pacific Menopause Federation(2007)。The History of the Federation,http://www.apmf.net/。  new window
16.Farrell, Elizabeth(2005)。Menopause Perspectives around the World: Asia Pacific: Asia Pacific Menopause Federation (APMF),http://www.imsociety.org/menopause_ perspectives _ around_the_world.php。  new window
圖書論文
1.戴東源(2012)。為何科學知識需要社會學的分析?科學知識社會學初探。科技與社會:社會建構論、科學社會學和知識社會學的視角。台北:群學。new window  延伸查詢new window
 
 
 
 
第一頁 上一頁 下一頁 最後一頁 top
:::
無相關著作
 
QR Code
QRCODE